HomeHealthcare & Life SciencesBiotechnology Peripheral Myelin Protein 22 Gene Related Disorder Market

United States Peripheral Myelin Protein 22 Gene Related Disorder Market Size & Outlook, 2026-2034


United States Peripheral Myelin Protein 22 Gene Related Disorder Market Insights

  • Reed Intelligence analysis indicates that the United States Peripheral Myelin Protein 22 Gene Related Disorder Market size, valued at USD 415.67 Million in 2025, is expected to expand to USD 870.47 Million by 2034.
  • The United States market is forecasted to expand at a CAGR of 8.53% spanning 2026–2034.
  • Charcot-Marie-Tooth Disease Type 1A (CMT1A) held the leading position among Type segments in 2025, based on market size.
  • Charcot-Marie-Tooth Disease Type 1A (CMT1A) is projected to post the fastest growth rate, sustaining its position as the most attractive Type segment during the forecast horizon.

Other Key Findings


  • In 2025, United States accounted for 26.31% of the global Peripheral Myelin Protein 22 Gene Related Disorder Market size.
  • By 2034, United States is expected to lead the global Peripheral Myelin Protein 22 Gene Related Disorder Market in terms of market size.
  • Within North America, United States is projected to dominate the regional Peripheral Myelin Protein 22 Gene Related Disorder Market size by 2034.
  • United States is identified as the fastest-growing market in North America, anticipated to reach USD 868.35 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 415.67 Million
Market Size In 2034 USD 870.47 Million
Largest segment Charcot-Marie-Tooth Disease Type 1A (CMT1A)
Units Revenue in USD Million
CAGR 8.53% (2026-2034)
Segmnetation Covered
Type
  1. Charcot-Marie-Tooth Disease Type 1A (CMT1A)
  2. Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)
Application
  1. Diagnostics
  2. Therapeutics
End-Use
  1. Hospitals and Clinics
  2. Research Institutes
  3. Diagnostic Laboratories
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports